远程康复对COVID-19后患有长期呼吸障碍的人的影响:一项随机对照研究
Canan Demir1, Cihan Caner Aksoy2, Gulhan Yilmaz Gokmen1
1Department of Cardiopulmonary Physiotherapy and Rehabilitation, Faculty of Health Sciences, Bandirma Onyedi Eylul University, Bandirma/Balikesir, Türkiye.
Journal of telemedicine and telecare
|May 6, 2025
概括
电话康复显著改善了长期COVID症状,如呼吸障碍和疲劳. 这些好处持续了12周,显示了其在COVID后恢复方面的有效性.
科学领域:
- 康复医学 康复医学 康复医学
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 持续性呼吸不全和疲劳是2019年新冠肺炎疾病 (COVID-19) 的常见后果.
- 对COVID-19后呼吸道症状的有效管理策略至关重要.
研究的目的:
- 评估远程康复在治疗COVID-19后持续性呼吸不良和相关症状方面的有效性.
- 评估随着时间的推移,运动能力,呼吸功能和疲劳的变化.
主要方法:
- 一项随机对照试验涉及36名参与者,他们患有COVID-19后呼吸障碍.
- 他们组成了三组:远程康复 (TRG),家庭炼 (HEG) 和控制 (CG).
- 评估包括呼吸障碍,运动能力,肌肉氧化,呼吸功能和疲劳在基线,6周和12周.
主要成果:
- 电力康复组 (TRG) 在第6周出现呼吸不全,疲劳,运动能力和呼吸肌肉强度的显著改善,在第12周持续.
- 家庭炼组 (HEG) 在呼吸障碍和疲劳方面有所改善,而对照组 (CG) 仅显示呼吸障碍的改善.
- 在任何组中都没有观察到肌肉氧化的显著变化.
结论:
- 监督的远程康复在改善和维持COVID-19后患者的关键症状方面是有效的.
- 在家练习对呼吸障碍和疲劳有一些好处,但远程康复提供了更广泛的改善.
- 电话康复为管理长期COVID症状提供了一种可行和结构化的方法.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
117
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
117
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
95
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
95
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K